We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 4.675 | 4.35 | 5.00 | - | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.52 | 9.41M |
| Date | Subject | Author | Discuss |
|---|---|---|---|
| 08/9/2020 07:42 | naplion - see ya! think your prediction of 150p is for the birds, and I think you'll regret selling, but we'll see... | sloppyjoe2 | |
| 08/9/2020 07:37 | Rubbish. A SAFE & TESTED Vaccine is couple yrs off yet... | bobby1904 | |
| 08/9/2020 07:32 | I think everyone was expecting better and more clear progress .. were I winter now and by the time they are done looks like the vaccine will be ready ... dont forget they still need to market it .. make it ... also its not just the are the 9nly ones offering solutions to treat the virus so its very competitive out there from a business point of view .the rns is written in a way that is not very positive not to say negative and there is a couple of statements on some results that are not very assuring but they tried to sugar quote it, if yiu re read it . You will notice it. Now that everyone was holding tight waiting for news and u get this .. peice is down to 150 today i estimate and if no news to come soon will drift back even more south Iam out while I can still | naplion | |
| 08/9/2020 07:31 | That part of trial is paused | 90005nelson |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
